A Study in Healthy Japanese and Caucasian Subjects to Assess the Pharmacokinetics, Safety and Tolerability of Risankizumab
Clinical trial NCT05305222 · COMPLETED
Trial details
- NCT number
- NCT05305222
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2018-06-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.